The makers of Ozempic say their weight-loss drug Wegovy will be available to patients in Canada starting Monday. Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity. …
Descrease article font size Increase article font size Canadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company …
Ozempic maker Novo Nordisk is facing a proposed class action lawsuit that alleges the company has not properly warned Canadians about severe side effects, including stomach paralysis and gallbladder disease. …